SCHEMBL261201

SCHEMBL261201

CC(C)C[S+](N)[O-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1691196 1.00
SCHEMBL894031 1.00
SCHEMBL21436820 0.73
SCHEMBL142518 0.72
SCHEMBL231002 0.72
SCHEMBL28690676 0.71
SCHEMBL22254242 0.69
SCHEMBL14080957 0.69
SCHEMBL515123 0.69
SCHEMBL1233578 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 986 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4380932-B1 PROCESS FOR PREPARING AFICAMTEN CYTOKINETICS INC (US) 2025-11-26 EP claimed
EP-4055015-B1 GEM-DISUBSTITUTED HETEROCYCLIC COMPOUNDS AND THEIR USE AS IDH INHIBITORS NERVIANO MEDICAL SCIENCES SRL (IT) 2025-04-02 EP claimed
US-12247024-B2 Process for preparing aficamten CYTOKINETICS, INC. (US) 2025-03-11 US claimed
US-12227522-B2 Synthesis of structural analogs of largazole and associated compounds COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2025-02-18 US claimed
EP-4380932-A1 PROCESS FOR PREPARING AFICAMTEN Cytokinetics, Inc. (US) 2024-06-12 EP claimed
US-20240150336-A1 PROCESS FOR PREPARING AFICAMTEN CYTOKINETICS, INC. 2024-05-09 US claimed
US-11932631-B2 Process for preparing aficamten CYTOKINETICS, INC. (US) 2024-03-19 US claimed
US-20240059709-A1 SYNTHESIS OF STRUCTURAL ANALOGS OF LARGAZOLE AND ASSOCIATED COMPOUNDS COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2024-02-22 US claimed
EP-4262795-A1 SYNTHESIS OF STRUCTURAL ANALOGS OF LARGAZOLE AND ASSOCIATED COMPOUNDS Colorado State University Research Foundation (US) 2023-10-25 EP claimed
EP-3768659-B1 AN IMPROVED ASYMMETRIC SYNTHESIS OF ALPHA-(DIARYLMETHYL) ALKYL AMINES PIRAMAL PHARMA LTD (IN) 2023-07-19 EP claimed
US-20210061752-A1 AN IMPROVED ASYMMETRIC SYNTHESIS OF alpha-(DIARYLMETHYL) ALKYL AMINES Piramal Enterprises Limited (IN) 2021-03-04 US claimed
US-10858315-B2 Method for preparing (R)-N-[4-(1-amino-ethyl)-2,6-difluoro-phenyl]-methanesulfonamide AMOREPACIFIC CORPORATION (KR) 2020-12-08 US claimed
US-20200031766-A1 METHOD FOR PREPARING (R)-N-[4-(1-AMINO-ETHYL)-2,6-DIFLUORO-PHENYL]-METHANESULFONAMIDE AMOREPACIFIC CORPORATION (KR) 2020-01-30 US claimed
US-20190144454-A1 COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT BLUEPRINT MEDICINES CORPORATION 2019-05-16 US claimed
EP-3409674-A1 COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT Blueprint Medicines Corporation (US) 2018-12-05 EP claimed
US-20140256952-A1 PROCESS FOR IXABEPILONE, AND INTERMEDIATES THEREOF SCINOPHARM TAIWAN, LTD. (TW) 2014-09-11 US claimed
US-20070254929-A1 Fluoro-and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof WYETH (US) 2007-11-01 US claimed
EP-1608638-A1 FLUORO-AND TRIFLUOROALKYL-CONTAINING HETEROCYCLIC SULFONAMIDE INHIBITORS OF BETA AMYLOID PRODUCTION AND DERIVATIVES THEREOF Wyeth (US) 2005-12-28 EP claimed
WO-2004092155-A1 FLUORO-AND TRIFLUOROALKYL-CONTAINING HETEROCYCLIC SULFONAMIDE INHIBITORS OF BETA AMYLOID PRODUCTION AND DERIVATIVES THEREOF WYETH (US) 2004-10-28 WO claimed
US-20040198778-A1 Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof WYETH 2004-10-07 US claimed